BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 32369567)

  • 1. Antitubercular Therapy Given to Differentiate Crohn's Disease From Intestinal Tuberculosis Predisposes to Stricture Formation.
    Gupta A; Pratap Mouli V; Mohta S; Kante B; Kalaivani M; Madhu D; Sahu P; Kumar S; Sharma R; Sahni P; Das P; Gupta SD; Makharia G; Kedia S; Ahuja V
    J Crohns Colitis; 2020 Nov; 14(11):1611-1618. PubMed ID: 32369567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic Antitubercular Therapy Is Associated With Accelerated Disease Progression in Patients With Crohn's Disease Receiving Anti-TNF Therapy: A Retrospective Multicenter Study.
    Liu F; Tang J; Ye L; Tan J; Qiu Y; Hu F; He J; Chen B; He Y; Zeng Z; Mao R; Cao Q; Gao X; Chen M
    Clin Transl Gastroenterol; 2022 Jun; 13(6):e00493. PubMed ID: 35758823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endoscopic and clinical responses to anti-tubercular therapy can differentiate intestinal tuberculosis from Crohn's disease.
    Pratap Mouli V; Munot K; Ananthakrishnan A; Kedia S; Addagalla S; Garg SK; Benjamin J; Singla V; Dhingra R; Tiwari V; Bopanna S; Hutfless S; Makharia G; Ahuja V
    Aliment Pharmacol Ther; 2017 Jan; 45(1):27-36. PubMed ID: 27813111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crohn's disease in India: a multicenter study from a country where tuberculosis is endemic.
    Das K; Ghoshal UC; Dhali GK; Benjamin J; Ahuja V; Makharia GK
    Dig Dis Sci; 2009 May; 54(5):1099-107. PubMed ID: 18770037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiating Crohn's disease from intestinal tuberculosis.
    Kedia S; Das P; Madhusudhan KS; Dattagupta S; Sharma R; Sahni P; Makharia G; Ahuja V
    World J Gastroenterol; 2019 Jan; 25(4):418-432. PubMed ID: 30700939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early treatment with anti-tumor necrosis factor agents improves long-term effectiveness in symptomatic stricturing Crohn's disease.
    Rodríguez-Lago I; Hoyo JD; Pérez-Girbés A; Garrido-Marín A; Casanova MJ; Chaparro M; Fernández-Clotet A; Castro-Poceiro J; García MJ; Sánchez S; Ferreiro-Iglesias R; Bastón I; Piqueras M; Careda LEIB; Mena R; Suárez C; Cordón JP; López-García A; Márquez L; Arroyo M; Alfambra E; Sierra M; Cano N; Delgado-Guillena P; Morales-Alvarado V; Aparicio JC; Guerra I; Aulló C; Merino O; Arranz L; Hidalgo MA; Llaó J; Plaza R; Molina G; Torres P; Pérez-Galindo P; Romero MG; Herrera-deGuise C; Armesto E; Mesonero F; Frago-Larramona S; Benítez JM; Calvo M; Martín MDCL; Elorza A; Larena A; Peña E; Rodríguez-Grau MDC; Miguel-Criado J; Botella B; Olmos JA; López L; Aguirre U; Gisbert JP;
    United European Gastroenterol J; 2020 Nov; 8(9):1056-1066. PubMed ID: 32723069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Routine diagnosis of intestinal tuberculosis and Crohn's disease in Southern India.
    Larsson G; Shenoy T; Ramasubramanian R; Balakumaran LK; Småstuen MC; Bjune GA; Moum BA
    World J Gastroenterol; 2014 May; 20(17):5017-24. PubMed ID: 24803814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is it possible to change phenotype progression in Crohn's disease in the era of immunomodulators? Predictive factors of phenotype progression.
    Magro F; Rodrigues-Pinto E; Coelho R; Andrade P; Santos-Antunes J; Lopes S; Camila-Dias C; Macedo G
    Am J Gastroenterol; 2014 Jul; 109(7):1026-36. PubMed ID: 24796767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in Disease Behaviour and Location in Patients With Crohn's Disease After Seven Years of Follow-Up: A Danish Population-based Inception Cohort.
    Lo B; Vester-Andersen MK; Vind I; Prosberg M; Dubinsky M; Siegel CA; Bendtsen F; Burisch J
    J Crohns Colitis; 2018 Feb; 12(3):265-272. PubMed ID: 29506105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for diagnostic delay in Crohn's disease and their impact on long-term complications: how do they differ in a tuberculosis endemic region?
    Banerjee R; Pal P; Girish BG; Reddy DN
    Aliment Pharmacol Ther; 2018 May; 47(10):1367-1374. PubMed ID: 29572889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolution of disease phenotype in adult and pediatric onset Crohn's disease in a population-based cohort.
    Lovasz BD; Lakatos L; Horvath A; Szita I; Pandur T; Mandel M; Vegh Z; Golovics PA; Mester G; Balogh M; Molnar C; Komaromi E; Kiss LS; Lakatos PL
    World J Gastroenterol; 2013; 19(14):2217-26. PubMed ID: 23599648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tubercular Intestinal Strictures Show a Poor Response to Anti-Tuberculous Therapy.
    Aggarwal P; Kedia S; Sharma R; Bopanna S; Madhusudhan KS; Yadav DP; Goyal S; Jain S; Mouli VP; Das P; Dattagupta S; Makharia G; Ahuja V
    Dig Dis Sci; 2017 Oct; 62(10):2847-2856. PubMed ID: 28856488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review article: the diagnosis and management of Crohn's disease in populations with high-risk rates for tuberculosis.
    Epstein D; Watermeyer G; Kirsch R
    Aliment Pharmacol Ther; 2007 Jun; 25(12):1373-88. PubMed ID: 17539977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short- and Long-term Outcomes Following Side-to-side Strictureplasty and its Modification Over the Ileocaecal Valve for Extensive Crohn's Ileitis.
    Bislenghi G; Ferrante M; Sabino J; Verstockt B; Martin-Perez B; Fieuws S; Wolthuis A; Vermeire S; D'Hoore A
    J Crohns Colitis; 2020 Oct; 14(10):1378-1384. PubMed ID: 32227163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk Stratification for Surgery in Stricturing Ileal Crohn's Disease: The BACARDI Risk Model.
    Bossuyt P; Debeuckelaere C; Ferrante M; de Buck van Overstraeten A; Vanbeckevoort D; Billiet T; Wolthuis A; Cleynen I; Van Assche G; D'Hoore A; Vermeire S
    J Crohns Colitis; 2018 Jan; 12(1):32-38. PubMed ID: 28981768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progression of Pediatric Crohn's Disease Is Associated With Anti-Tumor Necrosis Factor Timing and Body Mass Index Z-Score Normalization.
    Geem D; Hercules D; Pelia RS; Venkateswaran S; Griffiths A; Noe JD; Dotson JL; Snapper S; Rabizadeh S; Rosh JR; Baldassano RN; Markowitz JF; Walters TD; Ananthakrishnan A; Sharma G; Denson LA; Hyams JS; Kugathasan S
    Clin Gastroenterol Hepatol; 2024 Feb; 22(2):368-376.e4. PubMed ID: 37802268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. All that fistulises is not Crohn's disease: Multiple entero-enteric fistulae in intestinal tuberculosis.
    Singh H; Mandavdhare H; Sharma V
    Pol Przegl Chir; 2019 Jan; 91(1):35-37. PubMed ID: 30919818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Intestinal tuberculosis presenting as Crohn's disease].
    Suissa A; Militiano D; Kerner V; Rubin A; Eidelman S
    Harefuah; 1992 Nov; 123(9):322-3, 372. PubMed ID: 1473762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical Therapies for Stricturing Crohn's Disease: Efficacy and Cross-Sectional Imaging Predictors of Therapeutic Failure.
    Campos C; Perrey A; Lambert C; Pereira B; Goutte M; Dubois A; Goutorbe F; Dapoigny M; Bommelaer G; Hordonneau C; Buisson A
    Dig Dis Sci; 2017 Jun; 62(6):1628-1636. PubMed ID: 28401425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors associated with progression to surgery in Crohn's disease patients with endoscopic stricture.
    Mao R; Chen BL; He Y; Cui Y; Zeng ZR; Chen MH
    Endoscopy; 2014 Nov; 46(11):956-62. PubMed ID: 25325683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.